Register information Patent

DE file number : 60 2012 030 131.7 (Status: pending/in force, Query started: August 21, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2012 030 131.7
96EP file numberEAKZ12 72 5197.3
86WO file numberWAKZPCT/US2012/038297
97EP publication numberEPN2709986
87WO publication numberWPN2012158885
54Designation/titleTIDEUTERIERTE IVACAFTOR-DERIVATE
51IPC main classICM
(ICMV)		 C07D 215/56 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07B 59/00 (2006.01), A61K 31/47 (2006.01), A61P 11/12 (2006.01)
22DE application dateDATMay 17, 2012
96EP application dateEATMay 17, 2012
86WO application dateWATMay 17, 2012
43Date of first publicationOTNov 22, 2012
Date of publication of grantPETMar 22, 2017
71/73Applicant/ownerINHVERTEX PHARMACEUTICALS (EUROPE) LIMITED, London, GB
72InventorINMORGAN, Adam, J., AshlandMA 01721, US
74RepresentativeVTRHENKEL & PARTNER mbB, 80333 München, DE
Address for service Henkel & Partner mbB Patentanwaltskanzlei, Rechtsanwaltskanzlei, 80333 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201161487497 P
May 18, 2011
Due dateFT
FG		May 31, 2026
Annual fee for the 15th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002709986
Searchable text: EP000002709986
Original document: EP000002709986B1
Searchable text: EP000002709986B1
Original document: WO002012158885
Searchable text: WO002012158885
43Date of first publicationEVTNov 22, 2012
Date of the first transfer into DPMAregisterEREGTMay 8, 2014
Date of the (most recent) update in DPMAregisterREGTAug 15, 2025
(Show all update days)(Hide all update days)
  • Aug 15, 2025
    • Representative: changed
  • Jun 7, 2025
    • Due date: changed
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.03.2017: new
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 22.03.2017: deleted
  • May 8, 2014
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Nov 22, 2012  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Mar 26, 2014  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA May 8, 2014 May 8, 2014 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Mar 22, 2017  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Apr 27, 2017 Apr 27, 2017 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Jan 2, 2018 Mar 22, 2018 Details anzeigen
7 New applicant/owner details New applicant/owner details Feb 26, 2018 Apr 5, 2018 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTNov 22, 2012
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTMar 26, 2014
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 8, 2014
Issue numberHN19
YearPJ2014
Publication dateVTMay 8, 2014
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTMar 22, 2017
Date of update of the procedureREGTJun 7, 2025
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTApr 27, 2017
Issue numberHN17
YearPJ2017
Publication dateVTApr 27, 2017
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTJan 2, 2018
Issue numberHN12
YearPJ2018
Publication dateVTMar 22, 2018
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTFeb 26, 2018
Issue numberHN14
YearPJ2018
Publication dateVTApr 5, 2018
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHVERTEX PHARMACEUTICALS (EUROPE) LIMITED, London, GB
71/73Previous applicant/ownerINHFConcert Pharmaceuticals, Inc., Lexington, Mass., US